Soluble E-selectin levels in psoriatic patients treated with cyclosporin

European Journal of Dermatology

Volumn 6, Issue 4, 1996, Pages 297-299

  Carmona, Carlos ^a   Piñeyro, Inés ^a   Martínez, Miguel ^a   Macedo, Néstor Andrés ^a  

^a HOSPITAL DE CLÍNICAS   (Uruguay)

Author keywords

Cyclosporin; E selectin; Psoriasis

Indexed keywords

CYCLOSPORIN A; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PSORIASIS;

EID: 0029885163     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Zimmerman GA, Prescott SM, Mclntyre TM. Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today 1992; 13: 93-100.
2. Shimizu Y Newman W, Tanaka Y, et al. Lymphocyte interactions with endothelial cells. Immunol Today 1992; 13: 106-12.
3. Bevilacqua MP, Prober JS, Mendrick DL, et al. Identification of an inducible endotheliaf-leucocyte adhesion molecule. Proc Natl AcaJ Sci USA 1987; 84: 9238-42.
4. Prober JS, Bevilacqua MP, Mendrick DL, et al. Two distinct monokines, interleukin-1 and tumor necrosis factor, each independently induce the biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 1986; 136: 1680-7.
5. Shimizu Y, Shaws S, Graber N, et al. Activation-independent binding of human memory T cells to adhesion molecule ELAM1. Nature 1991; 349: 799-802.
6. Picker LJ, Kishimoto TK, Smith CW, et al. ELAM-1 is an adhesion molecule for skin-homing T cells. Nature 1991; 349: 796-9.
7. Picker LJ, Michie SA, Rott LS, et al. A unique phenotype of skin-associated lymphocytes in humans: preferential expression of the HECA-452 epitope by benign and malignant T-cells at cutaneous sites. Am J Pathol 1990; 136: 1053-68.
8. Berg EL, Yoshino T, Tott LS, et al. The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leucocyte adhesion molecule-1. J Exp Med 1991 ; 174: 1461-6.
9. Brandley BK, Swiedler SJ, Robbins PW. Carbohydrate ligands of the LEG cell adhesion molecules. Cell 1990; 63: 861-3.
10. Groves RW, Alien MH, Barker JNWN, et al. Endothelial leucocytes adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation, Br J Dermatol 1991; 124: 117-23.
11. Kyan-Aung U, Haskard DO, Psoton RN, et al. ELAM-1 and ICAM-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J Immunol 1991; 146: 512-28.
12. Norris PG, Barker JNWN, Allen MH, et al. Adhesion molecule expression in polymorphic light eruption. J Invest Dermatol 1992; 99: 504-8.
13. Rohde D, Schluter-Wigger W, Mielke V, et al. infiltration of both T cells and neutrophils in the skin is accompanied by the expression of endothelial leukocyte adhesion molecule-1 (ELAM-1): an immunohistochemical and ultrastructural study. J Invest Dermatol 1992; 98: 794-9.
14. Wakita H, Takigawa M. E-selectin and vascular cell adhesion molecule-1 are critical for initial trafficking of helper-inducer/memory T cells in psoriatic plaques. Arch Dermatol 1994; 130: 457-63.
15. Pigott R, Dillon LP, Hemingway IH, et al. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992; 187: 584-9.
16. Gearing AJH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-12.
17. Gearing AJH, Hemmingway I, Pigott R, et al. Soluble forms of vascular adhesion molecules E-selectin, ICAM-1 and VCAM-1: pathological significance. Ann NY Acad Sci 1992; 667: 324-31.
18. Newman W, Beall ID, Carson CW, et al. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 1993; 150: 644-54.
19. Lai CKW, Wong KC, Chan CHS, et al. Circulating adhesion molecules in tuberculosis. Clin Exp Immunol 1993; 94: 522-6.
20. Wenish C, Myskiw D, Parschalk B, et al. Soluble endothelin-associated adhesion molecules in patients with Graves disease. Clin Exp Immunol 1994; 98: 240-4.
21. Kim DS, Lee KY. Serum soluble E-selectin levels in Kawasaki disease. Scan J Rheumatol 1994; 23: 283-6.
22. Kowalzick K, Neuber M. Weichenthal I, et al. Elevated serum-soluble ELAM-1 levels in patients with severe plaque-type psoriasis. Arch Dermatol Res 1994; 286: 414-6.
23. Joost T, Bos JD , Heule F, et al. Low dose cyclosporin A in severe psoriasis. A double-blind study. Br J Dermatol 1988; 118: 183-91.
24. Ellis CN, Fradin MS, Messana JM, et al. Cyclosporin for plaque type psoriasis. Results of a multidose, double-blind trial. N Engl J Med 1991; 324: 277-84.
25. Wong RL, Winslow CM, Cooper KD. The mechanism of action of cyclosporin A in the treatment of psoriasis. Immunol Todav 1993; 14: 69-74.
26. Horrocks C, Duncan Jl, Oliver AM, et al. Adhesion molecule expression in psoriatic skin lesions and the influence of cyclosporin A. Clin Exp Immunol 1991; 84: 157-62.
27. Petzelbauer P, Stingl G. Wolff K, et al. Cyclosporin A suppresses ICAM-1 expression by papillary endothelium in healing psoriatic plaques. J Invest Dermatol 1991; 96: 362-9.
28. Edwards BD, Ballardie FW, Andrew SM, et al. Epidermal ICAM-1 in psoriasis after long-term cyclosporin. toncef 1991; ii: 1420.
29. Edwards BD, Andrew SM, O'Driscoll JB, et al. Changes in numbers of epidermal cell adhesion molecules caused by oral cyclosporin in psoriasis. J Clin Pathol 1993; 46: 713-7.
30. Ho VC, Griffiths CEM, Ellis CN, et al. Intralesional cyclosporin in the treatment of psoriasis. J Am Acad Dermatol 1990; 22: 242-5.
31. Ameglio F, Bonifati C, Carducci M, et al. Serum soluble E-selectin levels decrease early during effective therapy in psoriatic patients. Eur J Dermatol 1995; 512-5.
32. Groves RW, Kapahi P, Barker JNW, et al. Detection of circulating adhesion molecules in erythrodermic skin disease. J Am Acad Dermatol 1995; 32: 36.
33. Thomson AW, Nalesnik MA, Rilo HR, et al. ICAM-1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK 506 therapy. Autoimmunity 1993; 15: 215-23.
34. Level NJ, Munro CS, Higgins EM, et al. The absence of rapid relapse of psoriasis treated with cyclosporin A: a comparison with dithranol. Br J Dermatol 1992; 127 (suppl 40): 18 (abstract).